Fei Cao
Pain Medicine · Kansas City, MONPI 1598299687
Payments from drug & device makers
What this record shows
Abbott accounts for 61.8% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $4,524 and has fallen 91.0% since, to $405 in 2025.
Across 67 payments — averaging $99.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- SPR Therapeutics, Inc$825
- Nalu Medical, Inc.$448
- Boston Scientific$328
- Tris Pharma Inc$206
- Nevro Corp.$191
- plus $538 from 8 others
What the payments were for
- Travel & lodging$3,28950%
- Food & beverage$3,35250%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 26 | $4,105 |
| SPR Therapeutics, Inc | 14 | $825 |
| Nalu Medical, Inc. | 7 | $448 |
| Boston Scientific | 4 | $328 |
| Tris Pharma Inc | 2 | $206 |
| Nevro Corp. | 2 | $191 |
| Johnson & Johnson | 1 | $150 |
| Averitas Pharma Inc. | 3 | $136 |
| Tonix Medicines, Inc. | 1 | $77 |
| Vertex | 1 | $54 |
| Medtronic | 2 | $45 |
| GRT US Holding, Inc. | 2 | $35 |
| Curonix LLC | 1 | $21 |
| Globus Medical | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$2,686
- PRODIGY$1,069
- GENERAL PAIN MANAGEMENT$220
- SPRAVATO$150
- Omnia$127
- Dyanavel XR$125
- Quillichew ER$125
- Quillivant$125
- Nalu Neurostimulation System$118
- SPRINT PNS System$117
How this compares
$6,641 in reported general payments places this provider in the 75th percentile of 124 pain medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 130 | $24,155 |
| Buprenorphine | 65 | $12,270 |
| SavellaMilnacipran Hcl | 24 | $12,058 |
| Pregabalin | 247 | $7,901 |
| Duloxetine Hcl | 334 | $6,052 |
| Lidocaine | 85 | $4,969 |
| Gabapentin | 166 | $2,903 |
| Diclofenac Sodium | 67 | $2,238 |
| Cyclobenzaprine Hcl | 78 | $1,276 |
| Amitriptyline Hcl | 77 | $898 |
| Tizanidine Hcl | 59 | $767 |
| Buprenorphine Hcl | 29 | $756 |
| Baclofen | 82 | $708 |
| Celecoxib | 20 | $343 |
| Ondansetron Hcl | 22 | $291 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Kansas City
- Tyler ConcannonKansas City$64K
- Timothy StoppelmanKansas City$5K
- Curtis JohnsonKansas City$5K
- James JohnsonKansas City$3K
- Christopher ReisCape Girardeau$113K
- Anne ChristopherChesterfield$104K
- Vinicius Tieppo FrancioSaint Louis$35K
- Luvell GlantonHannibal$33K
- Jooyoung MaengSaint Louis$25K
- Travis FoxxLiberty$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.